(DD) Dupont De Nemours - NYSE
Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NYSE (USA) | Market Cap: 19.459m USD | Total Return: 73.9% in 12m
Avg Turnover: 154M
EPS Trend: 39.5%
Qual. Beats: 1
Rev. Trend: -59.4%
Qual. Beats: 0
Warnings
P/E ratio 126.4
Altman Z'' -0.33 < 1.0 - financial distress zone
Fakeout Below Avwap Earnings
Tailwinds
Confidence
DuPont de Nemours, Inc. is a global provider of technology-based materials and specialty solutions, operating primarily through its Healthcare & Water Technologies and Diversified Industrials segments. The company’s portfolio includes high-performance brands such as Tyvek, Styrofoam, and Corian, serving diverse end-markets including water filtration, construction, automotive, and aerospace. Following its 2019 separation from DowDuPont, the firm transitioned into a more focused multi-industrial entity headquartered in Wilmington, Delaware.
As a leader in the diversified chemicals sector, DuPont utilizes a research-intensive business model to develop specialized components like ion exchange resins and structural adhesives that are critical to industrial supply chains. The specialty chemicals industry often benefits from high barriers to entry due to proprietary formulations and the deep technical integration required for OEM applications. Investors can further analyze these competitive advantages and valuation metrics on ValueRay.
- Semiconductor market recovery drives demand for high-performance electronic materials and components
- PFAS litigation settlements and environmental remediation costs impact long-term liability projections
- Global industrial production trends dictate volume growth for specialty materials and adhesives
- Portfolio restructuring and divestiture of non-core assets influence shareholder capital returns
| Net Income: -29.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 2.06 > 1.0 |
| NWC/Revenue: 36.48% < 20% (prev 15.03%; Δ 21.46% < -1%) |
| CFO/TA 0.06 > 3% & CFO 1.29b > Net Income -29.0m |
| Net Debt (2.43b) to EBITDA (1.74b): 1.39 < 3 |
| Current Ratio: 2.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (412.8m) vs 12m ago -1.36% < -2% |
| Gross Margin: 33.79% > 18% (prev 32.76%; Δ 1.03% > 0.5%) |
| Asset Turnover: 33.79% > 50% (prev 33.88%; Δ -0.09% > 0%) |
| Interest Coverage Ratio: 3.39 > 6 (EBIT TTM 962.0m / Interest Expense TTM 284.0m) |
| A: 0.17 (Total Current Assets 5.64b - Total Current Liabilities 2.10b) / Total Assets 21.4b |
| B: -1.13 (Retained Earnings -24.2b / Total Assets 21.4b) |
| C: 0.03 (EBIT TTM 962.0m / Avg Total Assets 28.7b) |
| D: 1.95 (Book Value of Equity 14.0b / Total Liabilities 7.21b) |
| Altman-Z'' = -0.33 = B |
| DSRI: 0.93 (Receivables 1.70b/2.29b, Revenue 9.70b/12.2b) |
| GMI: 0.97 (GM 32.76% / 33.79%) |
| AQI: 0.87 (AQ_t 0.58 / AQ_t-1 0.66) |
| SGI: 0.80 (Revenue 9.70b / 12.2b) |
| TATA: -0.06 (NI -29.0m - CFO 1.29b) / TA 21.4b) |
| Beneish M = -3.34 (Cap -4..+1) = AA |
As of June 18, 2026, the stock is trading at USD 47.95 with a total of 3,599,865 shares traded.
Over the past week, the price has changed by +6.41%,
over one month by -1.42%,
over three months by +5.71% and
over the past year by +73.85%.
Dupont De Nemours has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy DD.
- StrongBuy: 11
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 56.8 | 18.5% |
P/E Trailing = 126.4211
P/E Forward = 20.202
P/S = 2.8128
P/B = 1.386
P/EG = 1.7173
Revenue TTM = 9.70b USD
EBIT TTM = 962.0m USD
EBITDA TTM = 1.74b USD
Long Term Debt = 3.13b USD (from longTermDebt, last quarter)
Short Term Debt = 40.0m USD (from shortTermDebt, last quarter)
Debt = 3.18b USD (from shortLongTermDebtTotal, last quarter) + Leases 9.00m
Net Debt = 2.43b USD (calculated: Debt 3.18b - CCE 752.0m)
Enterprise Value = 21.9b USD (19.5b + Debt 3.18b - CCE 752.0m)
Interest Coverage Ratio = 3.39 (Ebit TTM 962.0m / Interest Expense TTM 284.0m)
EV/FCF = 19.77x (Enterprise Value 21.9b / FCF TTM 1.11b)
FCF Yield = 5.06% (FCF TTM 1.11b / Enterprise Value 21.9b)
FCF Margin = 11.41% (FCF TTM 1.11b / Revenue TTM 9.70b)
Net Margin = -0.30% (Net Income TTM -29.0m / Revenue TTM 9.70b)
Gross Margin = 33.79% ((Revenue TTM 9.70b - Cost of Revenue TTM 6.42b) / Revenue TTM)
Gross Margin QoQ = 35.81% (prev 31.13%)
Tobins Q-Ratio = 1.02 (Enterprise Value 21.9b / Total Assets 21.4b)
Interest Expense / Debt = 8.93% (Interest Expense 284.0m / Debt 3.18b)
Taxrate = 21.39% (160.0m / 748.0m)
NOPAT = 756.2m (EBIT 962.0m * (1 - 21.39%))
Current Ratio = 2.68 (Total Current Assets 5.64b / Total Current Liabilities 2.10b)
Debt / Equity = 0.23 (Debt 3.18b / totalStockholderEquity, last quarter 14.0b)
Debt / EBITDA = 1.39 (Net Debt 2.43b / EBITDA 1.74b)
Debt / FCF = 2.19 (Net Debt 2.43b / FCF TTM 1.11b)
Total Stockholder Equity = 18.5b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.10% (Net Income -29.0m / Total Assets 21.4b)
RoE = -0.16% (Net Income TTM -29.0m / Total Stockholder Equity 18.5b)
RoCE = 4.45% (EBIT 962.0m / Capital Employed (Equity 18.5b + L.T.Debt 3.13b))
RoIC = 4.00% (NOPAT 756.2m / Invested Capital 18.9b)
WACC = 9.67% (E(19.5b)/V(22.6b) * Re(10.10%) + D(3.18b)/V(22.6b) * Rd(8.93%) * (1-Tc(0.21)))
Discount Rate = 10.10% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -51.11 | Cagr: -1.83%
[DCF] Terminal Value 70.85% ; FCFF base≈1.11b ; Y1≈1.11b ; Y5≈1.16b
[DCF] Fair Price = 30.44 (EV 14.8b - Net Debt 2.43b = Equity 12.3b / Shares 405.1m; r=9.67% [WACC]; 5y FCF grow -0.72% → 2.50% )
EPS Correlation: 39.47 | EPS CAGR: 4.95% | SUE: 1.58 | # QB: 1
Revenue Correlation: -59.40 | Revenue CAGR: -4.54% | SUE: 0.03 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.59 | Chg30d=-0.10% | Revisions=-7% | Analysts=14
EPS next Quarter (2026-09-30): EPS=0.64 | Chg30d=-0.05% | Revisions=+60% | Analysts=14
EPS current Year (2026-12-31): EPS=2.39 | Chg30d=-0.07% | Revisions=+76% | GrowthEPS=+42.1% | GrowthRev=+4.7%
EPS next Year (2027-12-31): EPS=2.62 | Chg30d=-0.04% | Revisions=+65% | GrowthEPS=+9.6% | GrowthRev=+3.9%
[Analyst] Revisions Ratio: +76%